Press Releases

Our press releases

• Bio-Path Holdings Provides Clinical Update and 2020 Business Outlook Jan 8 2020
• BIO-PATH HOLDINGS ANNOUNCES SUCCESSFUL COMPLETION OF SAFETY TESTING IN STAGE 2 OF PHASE 2 CLINICAL TRIAL IN ACUTE MYELOID LEUKEMIA Nov 26 2019
• Bio-Path Holdings Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market Nov 25 2019
• Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market Nov 21 2019
• BIO-PATH HOLDINGS ANNOUNCES CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR BP1002 Nov 21 2019
• BIO-PATH HOLDINGS REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS Nov 15 2019
• Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019 Nov 8 2019
• Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors Oct 15 2019
• Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent Sep 25 2019
• Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference Sep 3 2019